Aspira Women's Health Inc expected to post a loss of 24 cents a share - Earnings Preview

Aspira Women's Health

12/11/2024 13:52

* Aspira Women's Health Inc  AWH.OQ   AWH.O  is expected
to show a
rise in quarterly revenue when it reports  results on November
14 for the period ending September 30 2024
    * The Austin Texas-based  company is expected to report a
25.2% increase in revenue to $2.775 million from $2.22 million a
year ago, according to the mean estimate from 3 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Aspira Women's Health
Inc is
for a loss of 24 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aspira
Women's
Health Inc is $4.25​, above​ its last closing price of $0.86.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -0.31       -0.30      -0.28     Beat    8.2
 Jan. 1 0001   -0.33       -0.33      -0.39     Missed  -17.3
 Dec. 31 2023  -0.39       -0.45      -0.30     Beat    33​
 Jan. 1 0001   -0.45       -0.51      -0.48     Beat    5.4
 ​​Jun.        -0.55       -0.55      -0.28     Beat    49.1
 30 2023                                                
 Mar. 31 2023  -0.75       -0.75      -0.73     Beat    2.7​
 Dec. 31 2022  -1.05       -0.97                        38.5
 Sep. 30 2022  -0.98       -0.97                        -23.1
 This summary was machine generated November 12 at 13:52 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)